Ralph Harris

Sinclair Pharma Plc is a specialty pharmaceutical company. It provides solutions to treat wounds, which include skin disinfection, radiation dermatitis treatment and wounds and burns healing; dermatology, which include fungal infections, acne, atopic dermatitis and family dermatology; as well as oral diseases, which include gingivitis, periodontitis, mouth ulcers and teething through advanced surface technology and innovative delivery systems. The company was founded by Andrew Sinclair in 1971 and is headquartered in Godalming, the United Kingdom.

Andersen Piquet Ltd. provides executive search services in healthcare and life sciences markets. The company was founded by Sue Harris and is headquartered in Windlesham, the United Kingdom.

Prophilian Ltd. is a technology investment company. The compnay provides marketing as well as commercial and financial management services to pharmaceutical and biotechnology companies in Europe, North America, and Japan. Prophilian is headquartered in Ruddington, UK.

Aquapharm Biodiscovery Ltd. discovers and develops drugs. It develops products for application across the pharmaceutical, personal care and nutrition sectors. The company offers antibiotics, inflammation & dermatology, oxidative stress, high value ingredients and anti-oxidant ingredients. Aquapharm Biodiscovery was founded by Kathryn Fraser and Andrew Mearns Spragg on April 11, 2000 and is headquartered in Edinburgh, GB.

Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom.

Ocelus Ltd. is an early stage specialty pharmaceutical company, developing and commercializing the micro implant drug delivery system conceived by Dr Andrew Kirby. Founded in late 2007, Ocelus Ltd is based in South Wales, UK, Ocelus Ltd has been awarded two Welsh Assembly Government innovation grants, and has attracted venture capital funding from Finance Wales. Ocelus' technology was conceived as the answer for delivery of high molecular weight drugs through the skin. Micro needles and other poration technologies are low pain due to the size of the holes made, but suffer from problems in reproducibility of dose, and can only deliver relatively small quantities of drug, whereas large scale single implants are effective and incorporate controlled release of drug over time, but can be painful in use. Ocelus' technology was designed to combine the best of both systems, with small particles being simultaneously injected into the skin at hundreds of sites per square centimeter. These remain in the skin and dissolve rapidly or slowly to release drug.

Censo Biotechnologies Ltd. operates as stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. It offers human bio-sample procurement, IPSC generation & genome editing, IPSC differentiation, assay development and screening services. The company is headquartered in Midlothian, the United Kingdom.